RELX PLC (RELX) Discusses Business Services Strategy and Innovation in Fraud and Identity Solutions Transcript
RELX (RELX) is now rated a 'BUY' with a new ADR price target of $33.8, reflecting improved valuation and resilient fundamentals. RELX's data and workflow solutions, especially Lexis+, maintain a strong moat against generative AI disruption, supporting stable growth and margin expansion. Organic growth remains robust at 6-7%, with dividend yield above 2.75% and operating leverage from AI-driven efficiencies.
RELX (RELX) is rated a buy, with strong growth, high profitability, and a more reasonable valuation post-‘SaaSpocalypse' AI fears. RELX's legal and risk segments are well-protected by proprietary data, limiting AI disruption risk and supporting robust earnings growth guidance. Trading at a 20x forward P/E, RELX is fairly valued, with expected high single-digit EPS growth and a 2.5% progressive dividend yield.
| Media Industry | Communication Services Sector | Erik Engstrom CEO | XSTU Exchange | GB00B2B0DG97 ISIN |
| GB Country | 34,580 Employees | 8 May 2026 Last Dividend | 1 Jul 2015 Last Split | 7 Oct 1994 IPO Date |
RELX PLC operates as a leading provider of information-based analytics and decision tools for professional and business customers across the globe. With its roots stretching back to 1903 and a rebranding from Reed Elsevier PLC to RELX PLC in July 2015, the company has established its headquarters in London, United Kingdom. It serves a diverse audience in North America, Europe, and other international markets through its four primary segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. Each segment is tailored to meet the specialized needs of professionals in their respective fields, leveraging public and industry-specific content, technology, and algorithms to deliver impactful solutions.
This segment focuses on providing advanced analytics and decision tools that incorporate both public and industry-specific content, along with cutting-edge technology and algorithms. The primary aim is to assist clients in assessing and forecasting risk, making it invaluable for businesses looking to navigate uncertainties in their operations.
In the realm of research and healthcare, this segment delivers essential information and data sets. These resources support researchers and healthcare professionals by fostering advancements in science and health outcomes. Through access to critical data, this segment empowers the scientific community to make significant progress in their fields.
Providing a wealth of legal, regulatory, and business information and analytics, this segment is crafted to empower customers with the insights needed for informed decision-making. It enhances productivity among professionals by offering tools and resources that streamline the assimilation and application of legal knowledge in various professional settings.
This unique aspect of RELX PLC combines face-to-face interactions with data and digital tools to facilitate learning about markets, sourcing products, and completing transactions. It serves as a bridge between physical and digital marketplaces, enriching the customer experience with a comprehensive understanding of industry trends and opportunities.